PANEL DISCUSSION: BLOCKCHAIN USE CASES IN RARE DISEASE AND SOCIAL DETERMINANTS OF HEALTH (SDOH)

There is much talk of how Blockchain will revolutionize healthcare. This hype must be tempered by the fact that healthcare already has a trust factor built-in, or patients would not take pills prescribed by doctors, or let providers stick needles in their bodies.  It is often said that “Riches are in Niches,” and this is the case for blockchain and areas that are tangential to the direct care of the patient.As referenced in the 2015 ONC Interoperability Roadmap, Social Determinants of Health (SDoH) will need to be connected to the patients’ health status. Physicians currently monitor carboxyhemoglobin as an indicator of a patient’s level of smoking. As part of a smoking cessation program, a smart contract on the clinical Blockchain could identify normal blood carboxyhemoglobin (COhb) as reported by a clinical reference lab from the Laboratory Analyzer Blockchain and execute a request to increase an incentive benefit controlled by a “private / permissioned” USDA Clinical Blockchain. The clinical Blockchain will track the specific “chain of custody” from iStat Analyzer (Accriva, Radiometer, etc…) to the patient test results report, which triggers the smart contract with the USDA to distribute an incentive. Both the physician and the patient are notified of the disbursement. Similar use cases could be implemented for patients with diabetes, and obesity, helping people live healthy lives.

Moderator:
Edward Bukstel, CEO, Clinical Blockchain
Panelists:
Joe Guagliardo, Partner, Pepper Hamilton
Shereese Maynard, Public Health Consultant